Skip to Content

Frequently Searched

Supported by

Poster Library

The NCODA Poster Library is a comprehensive repository of educational and informational posters related to oncology pharmacy. It serves as a valuable resource for healthcare professionals seeking visual aids and up-to-date information to enhance patient care in oncology.

Use the links below to download posters from our international meetings.

Learn more about the poster presentation submission process.

Poster Opportunities

International Meetings Poster Links

Spring Forum 2025
Spring Forum 2024

Addressing Challenges of Pharmacy Practice in Non-Small Cell Lung Cancer (NSCLC): Insights from a Multi-Site Survey of Southeast U.S. Pharmacists

Adherence, Persistence, and Molecular response patterns in patients with CML treated with Tyrosine Kinase Inhibitors in an Integrated Health System Specialty Pharmacy

Adherence to recommended cardiac monitoring in breast cancer patients prescribed ribociclib

Appalachian Career Training in ONcology (ACTION) Program

Association between hemoglobin improvement and patient-reported outcomes in patients with myelofibrosis and anemia: post hoc pooled analysis of momelotinib phase 3 trials

Belantamab Mafodotin, Bortezomib, and Dexamethasone vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 DREAMM-7 Trial

Bispecific T-Cell Engagers (e.g., BiTEs): An Emerging Strategy for Immunotherapy

Breast Cancer Navigation: Improving Biopsy Time to Initiation of Treatment

Chemotherapy Regimen in the Home – It Takes a Village

Clinical Characteristics and Treatment Persistence in US Patients with HR+/HER2, Node Positive Early Breast Cancer Treated with Abemaciclib: Real-World Study from First Year After Approval

Cost-Offset Analysis Performed Utilizing cBTKi Safety Profiles Among Medicare Patients with Chronic Lymphocytic Leukemia

Development of a Comprehensive Workflow for the Management of Oral Anticancer Medications in an Integrated Health System Specialty Pharmacy

Distant Disease-Free Survival Across Key Subgroups From the Phase 3 NATALEE Trial of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Patients with HR+/HER2- Early Breast Cancer

Drug Monitoring in Community Oncology: Smart Monitoring & Backup Power for Safety and Savings

DSCSA 2025 Updates

Efficacy Outcomes by Minimal Residual Disease Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated with Belantamab Mafodotin Plus Bortezomib and Dexamethasone vs Daratumumab, Bortezomib, and Dexamethasone: Analysis from the DREAMM-7 Trial

EMBER-3: Study of Imlunestrant Alone or in Combination with Abemaciclib for Patients with ER+, HER2- ABC Following Progression on Previous ET

Empowering Oncology Pharmacy Technicians: The Impact of the Oncology Pharmacy Technician Community

Enhancing Early Cancer Detection and Treatment through Traditional Medicine Practitioners in Kenya

ENHERTU- New Indications – New Strategies for Oncology Practices

Establishment of the Oncology Pharmacogenetics Real-world Evidence Consortium (OPREC) to Demonstrate Clinical Utility of DPYD and Pharmacogenetic Testing via Real-world Evidence

Evaluation and Management of Cytokine Release Syndrome and Neurotoxicity Rates in Hematologic Malignancy Patients Treated with Bispecific Antibodies in Community Oncology Practice

Experienced or Perceived Burdens and Associated Quality-of-Life Impacts of Anemia and Transfusion Dependence in Myelofibrosis: A Patient Self-Report Survey Analysis

Exploring the multifaceted role of the APP in caring for patients with CLL

Hematologic Improvements Experienced by Pacritinib-Treated Patients with Myelofibrosis in Real-World Clinical Settings

Impact of Body Mass Index on the Safety and Efficacy of Ribociclib in Patients with HR+/HER2- Advanced Breast Cancer: Pooled Analysis of the MONALEESA-2, -3 and -7 Trials

Impact on healthcare resource utilization and cost of care of concomitant prescribing of Acid Reducing Agents with Tyrosine Kinase inhibitors: A US Payer Perspective

Impact of ribociclib dose reduction of efficacy in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer in NATALEE

Implementation of a Standardized Premedication Protocol for Prophylaxis of Carboplatin Hypersensitivity

Implementation of oral anticancer early monitoring using electronic questionnaires

Improvement in Serum Albumin as a Measure of Improved Metabolic Profile in Pacritinib-Treated Patients: A Retrospective Analysis of Patients Treated Across Three Clinical Trials

Improving Patient Access and Adherence: The Role of an Electronic Health Record (EHR)-Embedded Clinical Decision Support (CDS) Tool in Specialty Drug Management

INSIGHT: a phase 3, randomized, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal 

Integrated Efficacy and Safety Exposure Response (ER) Analysis of Tivozanib (Tivo) for the Treatment of Renal Cell Carcinoma (RCC)

Leading The Next Generation of Oncology Professionals

Leveraging Relationships with Drug Manufacturing Teams to Optimize Patient Outcomes

Long Covid, A Hidden Public Health Challenge: How It is Impacting Lives At A Local Based on Clinic Experience in Rural South Carolina

Lutetium-177 compared to emerging radionuclides in Prostate-Specific Membrane Antigen Castration-Resistant Prostate Cancer (PSMA_mCRPC)

Multiple and Rare Cancers Presenting Simultaneously in the Same Patient Post Covid 19 Infection: Case Report and Review of Literature

Non-pharmacological Interventions for Managing Abemaciclib-associated Adverse Events in Patients with Early/advanced HR+, HER2-Breast Cancer – A US-based Healthcare Provider Survey

Nurse-Led Improvements Earn Quality Oncology Accreditation

Optimizing Care in Non-Hodgkin’s Lymphoma (NHL): Evaluating the Operational Efficiencies of Dual-Indication Therapies

Oral Oncology Waste in an Integrated Health System Specialty Pharmacy

Pooled Analysis of Trastuzumab Deruxtecan (T-DXD) Retreatment After Recovery from Grade 1 Interstitial Lung Disease/Pneumonitis (ILD)

Real-world Risk od Recurrence by Nodal Status in Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer

Review of an in-house specialty pharmacy financial assistance program at a rural academic medical center

Rise in Unusual and Rare Cancers in Long Covid Patients: Rural Clinic Experience with Gastrointestinal Stromal Tumors (GIST)

Risk of Recurrence in Real-World (RW) NATALEE- and monarchE-Eligible Populations of Patients with HR+/HER2- Early Breast Cancer (EBC) in an Electronic Health Record (EHR)-Derived Database

Single-Dose Ferric Derisomaltose had the Highest Adherence Among Intravenous Iron Therapy in a National Community Oncology Network Real-World Analysis

Tarlatamab for Patients with Small Cell Lung Cancer6-8 Hour Outpatient vs 48-Hour Inpatient Monitoring in Cycle 1

The Impact of EHR-embedded Drug Substitution and Clinical Decision Support (CDS) in Oncology Care: A Case Study Highlighting Successful Implementation of a New EHR at The START Center for Cancer Care in San Antonio, TX

The Impact of Patient-Reported Adverse Events on Quality of Life: An Analysis of the DREAMM-7 and DREAMM-8 Randomized Controlled Trials

The NCODA Nursing Community: Strengthening Connections for Excellence in Patient Care

The role of comprehensive genomic profiling in distinguishing Desmoplastic Melanoma from Malignant Peripheral Nerve Sheath Tumor: Implications for treatment, prognosis, outcomes and delivering patient centered cancer care: Case report and impct on real world outcome.

The role of Social Determinant of Health (SDoH) and Health Related Social Needs (HrSN) data in addressing Cancer health Disparities (CHD) Think Global act local through Project No One Left Alone

Tolerability of First-Line Treatment with Ribociclib for Metastatic Breast Cancer Using 2 Large US Data Sources

A Multimodality Approach to Addressing New Drug Approvals

Addressing Barriers to Identifying HER2-Low Metastatic Breast Cancer Patients in a Large Community Oncology Practice

Administration of Ibrutinib Oral Suspension Via Nasogastric and Gastrostomy Tubes

ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients with Early-Stage ALK+ non-Small Cell Lung Cancer (NSCLC)

Becoming an Oncology Certified Pharmacy Technician- Oncology Pharmacy Technician Certification Program

Budget Impact of Selinexor Combination Regimens in Previously Treated Multiple Myeloma: An Oncology Network Perspective

Cancer Repository

Driving Speed-to-Medication Access

Evaluating Socioeconomic Status, Racial, and US Geographic Regional Differences in Biomarker Testing and Treatment in Advanced Ovarian Cancer

Early Identification for Fertility Preservation Improves Referrals in a Community Oncology Practice

Efficacy and Safety of First-Line Ribociclib + Letrozole in Patients with De Novo Metastatic Disease and Late Recurrence from (neo) Adjuvant Therapy in MONALEESA-2

Efficacy and Safety of Trifluridine/Tipiracilin Combination with Bevacizumab in Older and Younger Patients with Refractory Metastatic Colorectal Cancer: A Subgroup Analysis of the Phase 3 SUNLIGHT Trial

First-line Ribociclib + Endocrine Therapy vs Combination Chemotherapy in Aggressive HR+/HER2− Advanced Breast Cancer: A Subgroup Analysis of Patients With or Without Visceral Crisis From the Phase II RIGHT Choice Study

Health Advocates- Holistically Weaving Together Strategies That Illuminate The Path Toward Better Patient Outcomes

Hepatitis B Screening Practices in the Setting of Immunotherapy-Related Adverse Events

Impact of a Best Practices Program in Patients with Relapsed Refractory Multiple Myeloma Receiving Selinexor

Impact of Clinical Competency on the Prior Authorization Process

Impact of Nirogacestat on Functional Status in Patients with Desmoid Tumors: Results From the Phase 3 DeFi Study

Impact of Nursing in Preventing Patient Delays When Receiving Free Drug from the Manufacturer

KontRASt-01 Update Safety and Efficacy of JDQ443 in KRAS G12C-Mutated Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)

Launching a Centralized Financial Assistance Team – Increasing Medication Access

Leading The Next Generation of Oncology Professionals

Making a Difference in Your Community: NCODA’s Partnership with NMDP

Medically Integrated Dispensing- A Technicians Perspective

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool: An Online Method of Identifying and Preventing Drug Waste

Neurokinin-1 Antagonist Therapy Optimization Through a Systematic Approach at the University of New Mexico Comprehensive Cancer Center

Ocular Adverse Events (OAEs) in Newer Chemotherapeutic Agents: An Overview of Clinical Presentation and Management Strategies

Oncology Nurse Navigator Use of Clinical Decision Support Pathways to Support Remote Symptom Management (RSM) of Oncology Patients

Oncology Pharmacy Technician Association (OPTA)

Oral Oncology Risk Evaluation & Mitigation Strategies (REMS)

Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice

Patient Preferences for CDK4 6 Inhibitor Treatments in HR+ HER2− Early Breast Cancer- A Discrete Choice Survey Study

Platelet Response in Pacritinib-Treated Patients with Cytopenic Myelofibrosis: a Retrospective Analysis of PERSIST-2 and PAC203 Studies

Proactive Site of Care Evaluation for IVIG Infusion: Transition in Cancer Care Patients to Home Infusion

Readability of Online Patient and Physician Education Materials for Blood Cancer Diagnoses

Reclassification of ASCERTAIN (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) based on IPSS-R and IPSS-M Scoring Systems

Retrospective Analysis of the Relationship between Transfusion Independence and Bone Marrow Fibrosis Reduction in Patients with Myelofibrosis Treated with Pacritinib versus Ruxolitinib

Ribociclib + Nonsteroidal Aromatase Inhibitor as Adjuvant Treatment in Patients With HR+ HER2− Early Breast Cancer- Final Invasive Disease–Free Survival Analysis From the NATALEE Trial

Selinexor Dose Optimization Retrospective Analysis

Starting an Interprofessional PSO Chapter as a Distance Student

The NCODA Nursing Community- Where Collaboration and Innovation Cultivate Excellence in Oncology Care

Utilization of Positive Quality Interventions and Treatment Support Kits with Decitabine and Cedazurdine

XS004 Dasatinib (XS004) Improves Variability and Bioavailability in Humans Using Amorphous  Solid Dispersion Formulation of Dasatinib with Implications for Its Clinical Use